Through its non-profit initiative, the African Centre for Translational Genetics (ACTG), 54gene, the health technology company advancing African genomics research for improved global health outcomes, has completed its first consortium-led publication on over 100,000 Nigerians, as commissioned in 2020 at its launch. The Non-Communicable Diseases Genetic Heritage Study (NCD-GHS) consortium has published an article entitled…
54gene, a Nigerian health technology company advancing African genomics research for improved global health outcomes, has announced the launch of 7RiverLabs, its diagnostic arm. 54gene, founded in 2019, is a research, services, and development company that uses human genetic data from diverse African populations to improve the development, availability, and efficacy of medical products that…
Written by Tage Kene-Okafor Less than 3% of genetic material used in global pharmaceutical research is from Africa. The staggering gap is quite surprising because Africans and people of African descent are reported to be more genetically diverse than any other population. Since launching in 2019, African genomics startup 54gene has been at the forefront of bridging this divide in the global…